tiprankstipranks
Trending News
More News >
Lipigon Pharmaceuticals AB (SE:LPGO)
:LPGO
Sweden Market

Lipigon Pharmaceuticals AB (LPGO) Financial Statements

Compare
0 Followers

Lipigon Pharmaceuticals AB Financial Overview

Lipigon Pharmaceuticals AB's market cap is currently kr8.73M. The company's EPS TTM is kr-0.012; its P/E ratio is -0.11; Lipigon Pharmaceuticals AB is scheduled to report earnings on November 20, 2025, and the estimated EPS forecast is kr―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenuekr 10.29Mkr 16.41Mkr 390.00Kkr 3.18Mkr 4.28M
Gross Profitkr -26.29Mkr -5.12Mkr 366.00Kkr -36.04Mkr -4.72M
Operating Incomekr -25.58Mkr -12.37Mkr -37.74Mkr -41.19Mkr -7.82M
EBITDAkr -25.14Mkr -12.10Mkr -37.68Mkr -41.09Mkr -8.06M
Net Incomekr -25.26Mkr -12.13Mkr -37.67Mkr -41.12Mkr -8.07M
Balance Sheet
Cash & Short-Term Investmentskr 11.78Mkr 31.93Mkr 9.64Mkr 28.47Mkr 12.55M
Total Assetskr 14.82Mkr 33.60Mkr 10.82Mkr 29.43Mkr 15.24M
Total Debtkr 0.00kr 0.00kr 0.00kr 0.00kr 0.00
Net Debtkr -11.78Mkr -31.93Mkr -9.64Mkr -28.47Mkr -12.55M
Total Liabilitieskr 7.06Mkr 5.16Mkr 6.95Mkr 6.47Mkr 2.26M
Stockholders' Equitykr 7.76Mkr 28.45Mkr 3.87Mkr 22.96Mkr 12.98M
Cash Flow
Free Cash Flowkr -25.02Mkr -14.32Mkr -37.47Mkr -35.42Mkr -8.63M
Operating Cash Flowkr -24.78Mkr -14.32Mkr -37.47Mkr -35.30Mkr -8.63M
Investing Cash Flowkr -235.00Kkr 0.00kr 0.00kr -119.00Kkr 1.25M
Financing Cash Flowkr 4.58Mkr 36.70Mkr 18.61Mkr 51.09Mkr 18.88M
Currency in SEK

Lipigon Pharmaceuticals AB Earnings and Revenue History

Lipigon Pharmaceuticals AB Debt to Assets

Lipigon Pharmaceuticals AB Cash Flow

Lipigon Pharmaceuticals AB Forecast EPS vs Actual EPS